| Maria Fernanda Munoz, MD | |
|
140 Grandview Ave Ste 202, Waterbury, CT 06708 | |
| (203) 755-2344 | |
| (203) 573-8166 |
| Full Name | Maria Fernanda Munoz |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 140 Grandview Ave Ste 202, Waterbury, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407266901 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boca Raton Regional Hospital | Boca raton, FL | Hospital |
| Delray Medical Center | Delray beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Woman Care Llc | 5395807218 | 503 |
News Archive
Being overweight and obese during adolescence appears related to an increased risk of all-cause treated end-stage renal disease (ESRD) during a 25-year period, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
A technical advance in laboratory techniques may provide biology researchers broader access to RNA interference, a process of blocking the activity of targeted genes. RNA interference has recently emerged as an important tool in studying how genes function in normal biological processes and in disease.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, is pleased to announce that the company has been awarded $245,000, the maximum amount given for a grant under the US Qualifying Therapeutic Discovery Project (QTDP) Program.
Health care statistics for men are bleak: less than 50 percent have a primary care provider, their life expectancy is seven years less than women, fewer than half the men suffering from depression seek treatment and men have higher death rates than women in 14 of the top 15 leading causes of death.
A BREAKTHROUGH test for COVID-19 which works in just 25 minutes, with high accuracy and requiring only routine laboratory equipment, is currently in the final stages of clinical validation by British biotech firm MicrosensDx.
› Verified 2 days ago
| Entity Name | Florida Woman Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386823243 PECOS PAC ID: 5395807218 Enrollment ID: O20081230000509 |
News Archive
Being overweight and obese during adolescence appears related to an increased risk of all-cause treated end-stage renal disease (ESRD) during a 25-year period, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
A technical advance in laboratory techniques may provide biology researchers broader access to RNA interference, a process of blocking the activity of targeted genes. RNA interference has recently emerged as an important tool in studying how genes function in normal biological processes and in disease.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, is pleased to announce that the company has been awarded $245,000, the maximum amount given for a grant under the US Qualifying Therapeutic Discovery Project (QTDP) Program.
Health care statistics for men are bleak: less than 50 percent have a primary care provider, their life expectancy is seven years less than women, fewer than half the men suffering from depression seek treatment and men have higher death rates than women in 14 of the top 15 leading causes of death.
A BREAKTHROUGH test for COVID-19 which works in just 25 minutes, with high accuracy and requiring only routine laboratory equipment, is currently in the final stages of clinical validation by British biotech firm MicrosensDx.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maria Fernanda Munoz, MD 16244 S Military Trl Ste 230, Delray Beach, FL 33484-6505 Ph: (561) 499-2015 | Maria Fernanda Munoz, MD 140 Grandview Ave Ste 202, Waterbury, CT 06708 Ph: (203) 755-2344 |
News Archive
Being overweight and obese during adolescence appears related to an increased risk of all-cause treated end-stage renal disease (ESRD) during a 25-year period, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
A technical advance in laboratory techniques may provide biology researchers broader access to RNA interference, a process of blocking the activity of targeted genes. RNA interference has recently emerged as an important tool in studying how genes function in normal biological processes and in disease.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, is pleased to announce that the company has been awarded $245,000, the maximum amount given for a grant under the US Qualifying Therapeutic Discovery Project (QTDP) Program.
Health care statistics for men are bleak: less than 50 percent have a primary care provider, their life expectancy is seven years less than women, fewer than half the men suffering from depression seek treatment and men have higher death rates than women in 14 of the top 15 leading causes of death.
A BREAKTHROUGH test for COVID-19 which works in just 25 minutes, with high accuracy and requiring only routine laboratory equipment, is currently in the final stages of clinical validation by British biotech firm MicrosensDx.
› Verified 2 days ago
Janet L Vodra, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Grandview Ave, Suite 202, Waterbury, CT 06708 Phone: 203-755-2344 Fax: 203-573-8166 | |
Dr. Meghan Marie Slemmens, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Grandview Ave, Waterbury, CT 06708 Phone: 203-755-2344 Fax: 203-573-8166 | |
Dr. John Kaczmarek, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 134 Grandview Ave, Suite 210, Waterbury, CT 06708 Phone: 203-754-2535 Fax: 203-756-9921 | |
Mary L Zozulin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 60 Westwood Ave, Suite 100, Waterbury, CT 06708 Phone: 203-573-1425 | |
Clare Ventre, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 60 Westwood Ave, Suite 100, Waterbury, CT 06708 Phone: 203-573-1425 Fax: 203-573-8236 | |
Marc G. Hochler, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 56 Franklin St, Waterbury, CT 06706 Phone: 203-709-6000 | |
Jose Eguia, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 60 Westwood Ave, Suite 200, Waterbury, CT 06708 Phone: 203-574-5501 Fax: 203-596-0912 |